(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






2287 Result: Design

Sprout Closes on Phase 1A of North Vista Highlands - A Zero Energy Ready Residential Community In Pueblo Colorado

February 20th, 2019

PUEBLO, CO / CRWE PRESS RELEASE /  February 20, 2019 – Sprout Tiny Homes, Inc. (OTC PINK: STHI), an industry leader in designing, manufacturing, and developing state-of-the-art Zero Energy ready homes announced today that it has successful. Read more

Sprout Engages PCAOB-Registered Firm To Become Fully Reporting

January 09th, 2019

PUEBLO , CO / CRWE PRESS RELEASE / January 9, 2019 - Sprout Tiny Homes, Inc. (OTC PINK: STHI), an industry leader in the designing, manufacturing, and developing state of the art Zero Energy ready homes announced today that as part of its ongoin. Read more

Sprout Announces Plan in Preparation of U.S. Launch of Zero Energy Ready Homes to Meet Market Demand Following International Award Winning Project

December 19th, 2018

PUEBLO, CO / CRWE PRESS RELEASE  / December 19, 2018 - Sprout Tiny Homes (OTC: STHI) Following the recognition and Award Winning Design announcement at the October, 2018 meeting of the Urban Land Institute, presently with 40,000 members, and . Read more

iBrands Corporation Taps New CEO of Company; Acquires Canadian Conglomerate

May 07th, 2018

DALLAS, TX / CRWE PRESS RELEASE / May 7, 2018 / iBrands Corporation, Inc. (OTC PINK: IBRC) ("the Company"), a diversified holdings company, announces that it has appointed Patrick J. Johnson as the company's new CEO and President, and a. Read more

BlackBerry and Baidu Partnering to Accelerate Connected and Autonomous Vehicle Technology

January 04th, 2018

WATERLOO, ONTARIO and BEIJING, CHINA / CRWE PRESS RELEASE / Jan. 3, 2018 - BlackBerry Limited (NYSE:BB)(TSX:BB) and Baidu, Inc. (NASDAQ:BIDU) announced today that the two companies will collaborate to accelerate the deployment of connected and autono. Read more

Globalstar and Carmanah Sign Strategic Agreement

August 30th, 2016

VICTORIA, BC, CANADA / CRWE PRESS RELEASE / August 30, 2016 - Carmanah Technologies Corporation (TSX:CMH) (“Carmanah”) today announced a strategic agreement with Globalstar Inc (NYSE:GSAT) (“Globalstar”). Under the terms of th. Read more

New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker

August 28th, 2016

Results Featured at ESC 2016 Demonstrate Consistent, Sustained Safety and Effectiveness for the Medtronic Micra TPS DUBLIN and ROME / CRWE PRESS RELEASE / AUGUST 28, 2016 - In the largest and longest clinical evaluation of leadless pacing patients. Read more

Ballard's Protonex Subsidiary Introduces Clean Energy Fuel Cell Propulsion Systems for Civilian Unmanned Vehicles

August 24th, 2016

VANCOUVER, BC, CANADA and SOUTHBOROUGH, MA, USA / CRWE PRESS RELEASE / August 24, 2016 – Ballard Power Systems (NASDAQ: BLDP; TSX: BLD) today announced that the company’s subsidiary, Protonex, received notification from the U.S. Departmen. Read more

Trillium Therapeutics Receives FDA Clearance to Proceed With TTI-621 in Clinical Trial Targeting Solid Tumors and Mycosis Fungoides

August 17th, 2016

Toronto, Ontario / CRWE PRESS RELEASE / August 17, 2016 - Trillium Therapeutics Inc. (NASDAQ: TRIL; TSX: TR), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that the US Food . Read more

Seabridge Begins First Drill Campaign at Iskut High Grade Gold Project

August 15th, 2016

Toronto, Canada / CRWE PRESS RELEASE / August 15, 2016 - Seabridge Gold (TSX:SEA) (NYSE:SA) announced today that drilling has begun at its 100%-owned Iskut Project in northwestern British Columbia. The program calls for 3,000 meters of core drilling . Read more

ViewRay's MRIdian System Receives Japanese Regulatory Approval (Shonin)

August 15th, 2016

Expands MRI-Guided Radiation Therapy Access to World’s Third Largest Market CLEVELAND / CRWE PRESS RELEASE / August 15, 2016 – ViewRay, Inc. (Nasdaq: VRAY)announced today that the company received Shonin approval from the Japanese. Read more

Clean Energy Selected as Preferred Vendor for Cummins Facility Modifications; Opens Multiple Stations and Extends Long-Term Contracts

August 11th, 2016

NEWPORT BEACH, CALIF. / CRWE PRESS RELEASE / August 11, 2016 – Clean Energy Fuels Corp., (NASDAQ: CLNE) announced that it has been selected as a supplier to provide natural gas upgrades to facilities in Cummins Inc.’s Distribution Bu. Read more

Bombardier Named Preferred Bidder to Supply Rolling Stock for UK's East Anglia Franchise

August 11th, 2016

* BOMBARDIER AVENTRA vehicles will enable Abellio to ensure more reliable journeys with higher frequencies and reduced journey times Berlin, Germany / CRWE PRESS RELEASE / August 11, 2016 – Rail technology leader Bombardier Transportation ha. Read more

Pluristem's Phase III Critical Limb Ischemia Study Wins $8 Million Grant from Europe's Horizon 2020 Program

August 09th, 2016

- The study will enroll about 250 patients in Europe and the U.S. - The grant will cover a significant portion of the study expenses - PLX-PAD was previously selected by the EMA to be developed via the Adaptive Pathways project HAIFA, ISRAE. Read more

Pluristem Receives Positive Feedback from FDA and Gears Up for Phase III Trial of PLX-PAD in Critical Limb Ischemia

August 02nd, 2016

- CLI is a severe unmet medical need whose treatment addresses a $12 billion global market - Multinational study to be conducted in U.S. and Europe - Estimated trial enrollment of approximately 250 patients - Primary endpoint for BLA will be time . Read more

Load More Content